Caledonia spent the past year turning itself from a single-mine Zimbabwe gold producer into a funded developer with a second mine moving toward construction. The hinge event is the January 2026 offering of $150M in convertible senior notes, closed on upsized demand. Capped calls purchased alongside the notes raise the effective conversion price to $56.72, and net proceeds of roughly $130M converted a funding gap on the Bilboes sulphide project into a bankable path. At mid-year the company held net cash of $167.8M, more than a quarter of its $509M market capitalization. The stock's two-thirds rally from spring lows to $26.33 shows the market beginning to pay for the growth option rather than just for the operating mine. The debate is no longer whether Blanket is a good mine; it is whether the equity is a cheap claim on that mine plus a second one, or full payment for an asset whose build sits years away while the convert's dilution clock ticks.
The mechanics of that debate are clean and easy to lay out. Blanket is a mature mine coming off a record profit year, guiding to production of 72,000 to 76,500 ounces this year on revenue that rose by nearly half. The average realized gold price was $3,386 an ounce. The most recent quarter showed where the stress lines sit: Blanket produced 17,360 ounces, well below a record comparative quarter, and all-in sustaining cost, the industry's fully loaded per-ounce cost measure, jumped to $2,678. The hedge book now locks a $3,800 floor on part of production, protecting the build while capping some of the upside that gold bulls might otherwise harvest.
The read here is that the market is paying roughly cash value for the operating mine and assigning little credit to Bilboes beyond its accounting cost. That posture is fair given execution and jurisdiction risk, but it has never been tested with this much net cash and a funded feasibility study in place. The falsifiable clock runs through three data points: second-half grade recovery at Blanket, the closing of an interim funding package of up to $150M led by Stanbic and CBZ, and first gold at Bilboes by October 2028. A miss on any of the three re-rates the story back toward a single-asset Zimbabwe discount; a hit on all three makes the growth target the new base case.
Two features of the market backdrop frame everything else. Gold's move above $4,000 an ounce has handed every producer a windfall, but Caledonia's realization sits near the top of the peer set because its sales channel, for all its friction, prices off the international benchmark. And the share count has barely moved through the growth phase, with roughly 19.3M shares outstanding and no equity issuance funding the development push. That combination, record prices plus an undiluted share count, is why earnings per share nearly tripled last year and why the dilution question posed by the convert matters so much to the forward math. Investors are buying a company whose per-share economics have not yet been asked to fund the growth that is coming.